Albiglutide reduces cardiovascular events in patients with type 2 diabetes and existing cardiovascular disease
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD) and published in The Lancet shows that treatment with albiglutide (a type of drug called a glucagon-like peptide ...
Oct 2, 2018
0
4